Cellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in Canada
- Monday, April 27, 2020, 7:03
- Finance
- Add a comment
TEL AVIV, Israel , April 27, 2020 /PRNewswire/ — Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, received an official communication from the Canadian Intellectual Property Office regarding its intention…
About the Author
adminasapcorp has written 41532 stories on this site.